Wholesaler share of Rx market to top out at 85%, Cardinal predicts; mega-chains will maintain warehouses.
WHOLESALER SHARE OF Rx MARKET WILL PLATEAU AT 85%, CARDINAL Chief Operating Officer John Kane predicted at the Bear Stearns health care conference in New York City on Sept. 9. Noting that the wholesaler share of prescription drug distribution has increased to about 80% (a level reached in 1995), Kane said that Cardinal sees "this number leveling off." The limiting factor is the desire of "many of the chains [to] stay in warehousing," the Cardinal exec acknowledged. He said his firm is "still in discussions with many of [the chains] about getting out of it," but, with "the larger chains...taking over, we see about 85% being the maximum in today's health care scenario."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth